Friday 6 November 2026 Export QGEN’s income statement to Excel — free account

QIAGEN N.V.

QGEN Healthcare Diagnostics & Research

QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024.

Revenue: +0.28%
EPS: +7.94%
Free cash flow: +30.5%
Total debt: +13.8%

Quarter to June 2026, against a year earlier

50.88 0.05 +0.10%

Follow QGEN

Alert me

Market cap: $10.5B
P/E: 26.1×
Fwd P/E: 26.0×
Dividend yield: 0.69%
F-score: 8/9
Altman Z: 3.94
Beneish M: −2.60
Dividend safety: 66/100

Overview

QIAGEN N.V. (QGEN) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, QIAGEN N.V. (QGEN) trades at a P/E ratio of 26.1×. Over the past ten years it has ranged from 0.0× (June 2020) to 1,741× (August 2020); the current reading is higher than 30% of that period. That is below the Diagnostics & Research industry median of 34.5× and in line with the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/QGEN/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="QIAGEN N.V. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/QGEN/metrics/pe-ratio">QIAGEN N.V. (QGEN) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	23.5×	(81.59%)
FY2024	128×	328.80%
FY2023	29.7×	9.61%
FY2022	27.1×	7.89%
FY2021	25.2×	(27.18%)
FY2020	34.5×	—
FY2019	0.0×	—
FY2018	42.0×	(77.22%)
FY2017	184×	131.92%
FY2016	79.5×	64.68%

Period	P/E ratio	Change
Jun 2026	20.0×	(4.19%)
Mar 2026	20.9×	(10.93%)
Dec 2025	23.5×	(3.31%)
Sep 2025	24.3×	(14.49%)
42 more quarters	Free account

Against its own ten years

Low 0.0× High 1,741×

Ten-year median 39.4×

Current reading's percentile 28

Company	P/E ratio
RDNT RadNet, Inc. compare	n/m
GRAL GRAIL, Inc. compare	n/m
GH Guardant Health, Inc. compare	n/m
QGEN QIAGEN N.V.	26.1×
ICLR ICON PLC compare	34.5×
MEDP Medpace Holdings, Inc. compare	34.6×
RVTY Revvity Inc. compare	71.9×
BLLN BillionToOne, Inc. compare	88.7×
CRL Charles River Laboratories International, Inc. compare	300×
Diagnostics & Research industry median	34.5×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

QIAGEN N.V. (QGEN) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on QGEN

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on QGEN

Stockrow Weekly